Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2028

Q: Who are the key players in the over the counter otc drugs dietary supplements market?

Some of the key players are OTC, Pfizer Inc, Novartis International AG, Roche Holding AG, Merck& Co. Inc, Sanofi, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline PLC, Bayer Healthcare AG., Astrazeneca plc, Alacer Corp., Alcon, Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan plc, Reckitt Benckiser Plc, Bausch & Lomb, AbbVie, The Colgate-Palmolive Company, Russia, Others.

Code: QYRE-Auto-4E3262

Report

January 2022

Pages:127

QYResearch

Description

Table of Content

Tables & Figures

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.

Market Analysis and Insights: Global Over the Counter (OTC) Drugs & Dietary Supplements Market

The global Over the Counter (OTC) Drugs & Dietary Supplements market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Analgesic & Pain Relievers accounting for % of the Over the Counter (OTC) Drugs & Dietary Supplements global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

China Over the Counter (OTC) Drugs & Dietary Supplements market size is valued at US$ million in 2021, while the North America and Europe Over the Counter (OTC) Drugs & Dietary Supplements are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Over the Counter (OTC) Drugs & Dietary Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Over the Counter (OTC) Drugs & Dietary Supplements market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Over the Counter (OTC) Drugs & Dietary Supplements market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Over the Counter (OTC) Drugs & Dietary Supplements market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Over the Counter (OTC) Drugs & Dietary Supplements market.

Global Over the Counter (OTC) Drugs & Dietary Supplements Scope and Market Size

Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Analgesic & Pain Relievers

Dermatological Products

Cough, Cold, and Flu Products

Vitamin Supplements

Mineral Supplements

Ophthalmic Products

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Others

BY COMPANY

Pfizer Inc.

Novartis International AG

Roche Holding AG

Merck & Co., Inc.

Sanofi S.A

Johnson & Johnson

Gilead Sciences

GlaxoSmithKline plc.

Bayer Healthcare AG

AstraZeneca plc.

Alacer Corp.

Alcon Inc.

Alfresa Pharma Corporation

Alkalon A/S

Alliance Healthcare

Allergan, Plc.

Reckitt Benckiser Plc.

Bausch & Lomb

AbbVie Inc.

The Colgate-Palmolive Company

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Analgesic & Pain Relievers

1.2.3 Dermatological Products

1.2.4 Cough, Cold, and Flu Products

1.2.5 Vitamin Supplements

1.2.6 Mineral Supplements

1.2.7 Ophthalmic Products

1.3 Market by Application

1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2017-2028)

2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region

2.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2017-2022)

2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2023-2028)

2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics

2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends

2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers

2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges

2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue

3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2017-2022)

3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2017-2022)

3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue

3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio

3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2021

3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served

3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service

3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type

4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2017-2022)

4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2023-2028)

5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application

5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2017-2022)

5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)

6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

6.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)

6.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)

6.2.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)

6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)

6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)

6.3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)

6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country

6.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)

6.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)

7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

7.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)

7.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)

7.2.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)

7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

7.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)

7.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)

7.3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)

7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country

7.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)

7.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)

8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

8.2.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)

8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

8.3.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)

8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region

8.4.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)

9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

9.2.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)

9.2.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)

9.2.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)

9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

9.3.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)

9.3.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)

9.3.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)

9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country

9.4.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)

9.4.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)

10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type

10.2.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)

10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application

10.3.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)

10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country

10.4.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Pfizer Inc.

11.1.1 Pfizer Inc. Company Details

11.1.2 Pfizer Inc. Business Overview

11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.1.5 Pfizer Inc. Recent Developments

11.2 Novartis International AG

11.2.1 Novartis International AG Company Details

11.2.2 Novartis International AG Business Overview

11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.2.5 Novartis International AG Recent Developments

11.3 Roche Holding AG

11.3.1 Roche Holding AG Company Details

11.3.2 Roche Holding AG Business Overview

11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.3.5 Roche Holding AG Recent Developments

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Details

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.4.5 Merck & Co., Inc. Recent Developments

11.5 Sanofi S.A

11.5.1 Sanofi S.A Company Details

11.5.2 Sanofi S.A Business Overview

11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.5.5 Sanofi S.A Recent Developments

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.6.5 Johnson & Johnson Recent Developments

11.7 Gilead Sciences

11.7.1 Gilead Sciences Company Details

11.7.2 Gilead Sciences Business Overview

11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.7.5 Gilead Sciences Recent Developments

11.8 GlaxoSmithKline plc.

11.8.1 GlaxoSmithKline plc. Company Details

11.8.2 GlaxoSmithKline plc. Business Overview

11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.8.5 GlaxoSmithKline plc. Recent Developments

11.9 Bayer Healthcare AG

11.9.1 Bayer Healthcare AG Company Details

11.9.2 Bayer Healthcare AG Business Overview

11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.9.5 Bayer Healthcare AG Recent Developments

11.10 AstraZeneca plc.

11.10.1 AstraZeneca plc. Company Details

11.10.2 AstraZeneca plc. Business Overview

11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.10.5 AstraZeneca plc. Recent Developments

11.11 Alacer Corp.

11.11.1 Alacer Corp. Company Details

11.11.2 Alacer Corp. Business Overview

11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.11.5 Alacer Corp. Recent Developments

11.12 Alcon Inc.

11.12.1 Alcon Inc. Company Details

11.12.2 Alcon Inc. Business Overview

11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.12.5 Alcon Inc. Recent Developments

11.13 Alfresa Pharma Corporation

11.13.1 Alfresa Pharma Corporation Company Details

11.13.2 Alfresa Pharma Corporation Business Overview

11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.13.5 Alfresa Pharma Corporation Recent Developments

11.14 Alkalon A/S

11.14.1 Alkalon A/S Company Details

11.14.2 Alkalon A/S Business Overview

11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.14.5 Alkalon A/S Recent Developments

11.15 Alliance Healthcare

11.15.1 Alliance Healthcare Company Details

11.15.2 Alliance Healthcare Business Overview

11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.15.5 Alliance Healthcare Recent Developments

11.16 Allergan, Plc.

11.16.1 Allergan, Plc. Company Details

11.16.2 Allergan, Plc. Business Overview

11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.16.5 Allergan, Plc. Recent Developments

11.17 Reckitt Benckiser Plc.

11.17.1 Reckitt Benckiser Plc. Company Details

11.17.2 Reckitt Benckiser Plc. Business Overview

11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.17.5 Reckitt Benckiser Plc. Recent Developments

11.18 Bausch & Lomb

11.18.1 Bausch & Lomb Company Details

11.18.2 Bausch & Lomb Business Overview

11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.18.5 Bausch & Lomb Recent Developments

11.19 AbbVie Inc.

11.19.1 AbbVie Inc. Company Details

11.19.2 AbbVie Inc. Business Overview

11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.19.5 AbbVie Inc. Recent Developments

11.20 The Colgate-Palmolive Company

11.20.1 The Colgate-Palmolive Company Company Details

11.20.2 The Colgate-Palmolive Company Business Overview

11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction

11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

11.20.5 The Colgate-Palmolive Company Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Analgesic & Pain Relievers

Table 3. Key Players of Dermatological Products

Table 4. Key Players of Cough, Cold, and Flu Products

Table 5. Key Players of Vitamin Supplements

Table 6. Key Players of Mineral Supplements

Table 7. Key Players of Ophthalmic Products

Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022) & (US$ Million)

Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2017-2022)

Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2023-2028)

Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends

Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers

Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges

Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2017-2022) & (US$ Million)

Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players (2017-2022)

Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2021)

Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2021

Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2017-2022)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service

Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2017-2022)

Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2023-2028)

Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2017-2022)

Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2023-2028)

Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)

Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)

Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)

Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)

Table 41. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)

Table 43. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 44. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)

Table 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)

Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)

Table 47. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 48. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)

Table 49. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 50. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)

Table 51. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022) & (US$ Million)

Table 52. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028) & (US$ Million)

Table 53. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 54. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)

Table 55. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 56. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)

Table 57. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)

Table 58. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)

Table 63. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)

Table 64. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)

Table 65. Pfizer Inc. Company Details

Table 66. Pfizer Inc. Business Overview

Table 67. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 68. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 69. Pfizer Inc. Recent Developments

Table 70. Novartis International AG Company Details

Table 71. Novartis International AG Business Overview

Table 72. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 73. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 74. Novartis International AG Recent Developments

Table 75. Roche Holding AG Company Details

Table 76. Roche Holding AG Business Overview

Table 77. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 78. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 79. Roche Holding AG Recent Developments

Table 80. Merck & Co., Inc. Company Details

Table 81. Merck & Co., Inc. Business Overview

Table 82. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 83. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 84. Merck & Co., Inc. Recent Developments

Table 85. Sanofi S.A Company Details

Table 86. Sanofi S.A Business Overview

Table 87. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 88. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 89. Sanofi S.A Recent Developments

Table 90. Johnson & Johnson Company Details

Table 91. Johnson & Johnson Business Overview

Table 92. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 93. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 94. Johnson & Johnson Recent Developments

Table 95. Gilead Sciences Company Details

Table 96. Gilead Sciences Business Overview

Table 97. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 98. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 99. Gilead Sciences Recent Developments

Table 100. GlaxoSmithKline plc. Company Details

Table 101. GlaxoSmithKline plc. Business Overview

Table 102. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 103. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 104. GlaxoSmithKline plc. Recent Developments

Table 105. Bayer Healthcare AG Company Details

Table 106. Bayer Healthcare AG Business Overview

Table 107. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 108. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 109. Bayer Healthcare AG Recent Developments

Table 110. AstraZeneca plc. Company Details

Table 111. AstraZeneca plc. Business Overview

Table 112. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 113. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 114. AstraZeneca plc. Recent Developments

Table 115. Alacer Corp. Company Details

Table 116. Alacer Corp. Business Overview

Table 117. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 118. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 119. Alacer Corp. Recent Developments

Table 120. Alcon Inc. Company Details

Table 121. Alcon Inc. Business Overview

Table 122. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 123. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 124. Alcon Inc. Recent Developments

Table 125. Alfresa Pharma Corporation Company Details

Table 126. Alfresa Pharma Corporation Business Overview

Table 127. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 128. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 129. Alfresa Pharma Corporation Recent Developments

Table 130. Alkalon A/S Company Details

Table 131. Alkalon A/S Business Overview

Table 132. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 133. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 134. Alkalon A/S Recent Developments

Table 135. Alliance Healthcare Company Details

Table 136. Alliance Healthcare Business Overview

Table 137. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 138. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 139. Alliance Healthcare Recent Developments

Table 140. Allergan, Plc. Company Details

Table 141. Allergan, Plc. Business Overview

Table 142. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 143. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 144. Allergan, Plc. Recent Developments

Table 145. Reckitt Benckiser Plc. Company Details

Table 146. Reckitt Benckiser Plc. Business Overview

Table 147. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 148. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 149. Reckitt Benckiser Plc. Recent Developments

Table 150. Bausch & Lomb Company Details

Table 151. Bausch & Lomb Business Overview

Table 152. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 153. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 154. Bausch & Lomb Recent Developments

Table 155. AbbVie Inc. Company Details

Table 156. AbbVie Inc. Business Overview

Table 157. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 158. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 159. AbbVie Inc. Recent Developments

Table 160. The Colgate-Palmolive Company Company Details

Table 161. The Colgate-Palmolive Company Business Overview

Table 162. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product

Table 163. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)

Table 164. The Colgate-Palmolive Company Recent Developments

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2021 VS 2028

Figure 2. Analgesic & Pain Relievers Features

Figure 3. Dermatological Products Features

Figure 4. Cough, Cold, and Flu Products Features

Figure 5. Vitamin Supplements Features

Figure 6. Mineral Supplements Features

Figure 7. Ophthalmic Products Features

Figure 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2021 VS 2028

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacy Case Studies

Figure 12. Others Case Studies

Figure 13. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered

Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2021 VS 2028

Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2021

Figure 18. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2021)

Figure 19. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2021

Figure 20. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)

Figure 21. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)

Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)

Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)

Figure 24. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)

Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)

Figure 28. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)

Figure 29. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)

Figure 30. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)

Figure 37. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)

Figure 38. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)

Figure 39. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Region (2017-2028)

Figure 40. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 45. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)

Figure 47. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)

Figure 48. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)

Figure 49. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)

Figure 50. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 51. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)

Figure 53. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)

Figure 54. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)

Figure 55. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)

Figure 56. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 58. UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 59. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 60. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 61. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 62. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 63. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 64. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 65. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 67. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 68. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 69. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 70. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 71. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 72. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 73. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 74. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 75. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 76. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 77. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 78. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-4E3262

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-5U3847

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-22P5979

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-33X610

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16X3680

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions